As part of our continued coverage on COVID-19 cases and recovery, we will look at how the Coronavirus pandemic in Spring 2021 is being handled and contained – and what we may expect moving forward.
In today’s article we will take a look at:
Vaccine Roll-out Spring 2021
Side Effects and Effectiveness
AstraZeneca going to other countries
US and Worldwide COVID Case Load
International Travel Restrictions
Economy spring 2021
We hope that each and every one of you – and all your loved ones – stay healthy and safe. Let’s not forget the priorities in these trying times. We can also keep our chins up, knowing better times are ahead.
Vaccine Rollout Spring 2021
In the US, as of April 26, 2021
• At least 140,969,663 people or 42% of the population have received at least one dose.
• Overall, 87,867,908 people or 26% of the population have been fully vaccinated.
• In the US, 290,692,005 doses have been distributed so far, with 79% or 230,768,454 of the doses used.
The vaccine makers use 2 different types of delivery systems: mRNA or Viral Vector, the main practical difference being the viral vector delivery can be issued as 1 dose.
J&J COVID-19 Vaccine:
• Headaches, fatigue and muscle pain were some of the most common side effects from J&J’s Covid-19 vaccine, according to a new FDA report.
• Roughly 40% of people reported headaches and just more than 38% reported feeling fatigued, the report said.
You certainly can continue to [get routine tests], but it would be highly unlikely that you’re ever going to test positive.
The vaccine, we now know, protects against symptomatic infections and also appears to protect against any kind of meaningful transient infections as well. Does that mean that you can never get infected? No, but it’s just much less likely.”
But as Saag clarified, the vaccines, while extremely effective, still don’t provide a 100-percent guarantee against infection. Researchers are still observing how well the existing vaccines protect against variants. So far, the mRNA vaccines (Moderna and Pfizer) appear to protect against known variants in the United States.
According to the CDC, even though the vaccine is proving effective at preventing against symptomatic infections, travel within and without the US is discouraged until more people have been vaccinated and the outbreak shows better containment stabilization.
White House Press Secretary Jen Psaki described that given the robust portfolio of Coronavirus vaccines that America has already approved and that is available in huge quantities, including 2-dose vaccines and 1-dose vaccine, and given that AstraZeneca isn’t authorized for use in the U.S., they don’t need to use AstraZeneca in their country against Coronavirus in the upcoming few months.
The doses were sent to Mexico as part of an agreement with the administration of President Joe Biden for 2.7 million shots of AstraZeneca’s vaccine to help supplement Mexico’s vaccination campaign amid global delays and shortages.
On Sunday April 25th, the United States reported a 14% decline in the seven-day average of new COVID-19 cases per day, according to a CNBC analysis of Johns Hopkins University data. Fauci said there have been about 3 million vaccinations per day.
Worldwide case load
As of April 20th, 2021 US State Department officials report more than 142.2 million cases of COVID-19 across the globe, with more with 3 million deaths.
As the Coronavirus mutates many people question how effective the new vaccines will be against the new variants.
All three variants of concern have been found in the U.S., as well as in a broad swath of other countries. And across the world, there are 10 vaccines in play. So this question – how well does each of the vaccines work against each of the worrying mutant strains? – it’s one of the hottest topics in biomedical research right now.
An experiment found that for AstraZeneca, it takes 86 times as many antibodies to neutralize the variant in South Africa compared to the original strain, meaning that this particular vaccine is not effective against that Coronavirus variant.
The consensus among disease experts is that as more data comes in, particular vaccines will be recommended to combat specific strains, and that these recommendations will change as variant predominance alters.
The change “will result in a significant increase in the number of countries at Level 4: Do Not Travel, to approximately 80% of countries worldwide,” the department said in a media note. “This does not imply a reassessment of the current health situation in a given country, but rather reflects an adjustment in the State Department’s Travel Advisory system to rely more on CDC’s existing epidemiological assessment.”
Economy Spring 2021
Probably one of the most surprising – and positive – pieces of news regarding the pandemic this spring is how well the economy and market have recovered after the initial downturn a year ago.
A year ago, the U.S. registered its deepest economic contraction since the Second World War. One year later, the economy is poised to post its strongest year of growth in almost four decades.
Economic activity is gaining traction, thanks to expanding vaccine distribution, lowered public health restrictions and substantial fiscal support. For the first time since the outbreak, the economic risks for the U.S. are tilted to the upside. Inflation will return, but won’t run out of control for reasons highlighted here.
The outlook is generally brightening, but uncertainty around the efficacy of current vaccines against mutated versions of the virus, which would cause a return of lockdowns, remains a key risk.
The outlook for high net-worth investors in 2021 is caution mixed with opportunity. Some of the markets and asset classes to consider include:
Private Equity Funds
Real Estate – particularly Florida and other migration destinations
Fintech and Tech stocks
The first 2 options should suit the mid to long term investment profile, while the market, although soaring, is more volatile, and will be treated accordingly.
The Coronavirus contains to wreak havoc, destroy lives and create uncertainty. Yet, with the best information and technology possible, we can, and will, find ourselves on the road to recovery, in our health, in our communities, and in our economies.
The vaccines and their continued roll-out will help to create a more calm and normalized social atmosphere, where we can begin assuming our normal lives once again, after 2 years of loss and intense restrictions. In the meantime, don’t forget to take advantage of the market sectors that are currently hot.
Take the opportunity to book a no obligation appointment with one of our investment analysts today.